Anaplastic Lymphoma Kinase (ALK) -Positive Non-small Cell Lung Cancer (NSCLC)

Details

Files
Project Status:
Open for Stakeholder Feedback
Therapeutic Area:
Anaplastic Lymphoma Kinase (ALK) -Positive Non-small Cell Lung Cancer (NSCLC)
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0058-000

Review Type: Rapid

Provisional Funding Algorithm

Draft Report Posted: 28-Nov-2024
Feedback Deadline: 5-Dec-2024
Final Report Posted (Target): 4-Feb-2024